This is a unique opportunity to access 47.5 ha of land, with associated infrastructure within the GlaxoSmithKline plant in Irvine, North Ayrshire. Businesses within the life sciences sector can benefit from established infrastructure, linking to existing operations, utilities, services, water-treatment or renewables. Enhanced capital allowances are available as a result of the Enterprise Area designation. Find out more about the GSK Life Sciences Campus on our project pages.
Call John Adam on